February 8, 2021 Quanterix Announces Closing of Public Offering Including Exercise of Underwriters’ Option to Purchase Additional Shares read more
February 3, 2021 Quanterix Announces Proposed Public Offering of $200.0 Million of its Common Stock read more
January 11, 2021 Quanterix Receives FDA Emergency Use Authorization for SARS-CoV-2 N Protein Antigen Test read more
December 29, 2020 Quanterix Receives FDA Emergency Use Authorization for Semi-Quantitative Antibody Test read more
October 29, 2020 Quanterix Corporation To Release Third Quarter 2020 Financial Results On November 5, 2020 read more